Resonance Health Limited (ASX:RHT)

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Services	4.54M
Services Growth	3.10%
Clinical Research Organisation	3.84M
TrialWest	204.75K

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Asia/Pacific	4.32M
Asia/Pacific Growth	1369.51%
North America	2.64M
North America Growth	-5.19%
EMEA	1.64M
EMEA Growth	22.89%